166 related articles for article (PubMed ID: 25078073)
1. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486).
Touat M; Lombardi G; Farina P; Kalamarides M; Sanson M
Acta Neurochir (Wien); 2014 Oct; 156(10):1831-5. PubMed ID: 25078073
[TBL] [Abstract][Full Text] [Related]
2. Mifepristone (RU 486) treatment of meningiomas.
Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
[TBL] [Abstract][Full Text] [Related]
4. The role of mifepristone in the management of meningiomas: A systematic review of literature.
Sharma R; Garg K; Katiyar V; Tandon V; Agarwal D; Singh M; Chandra SP; Suri A; Kale SS; Mahapatra AK
Neurol India; 2019; 67(3):698-705. PubMed ID: 31347538
[TBL] [Abstract][Full Text] [Related]
5. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
[TBL] [Abstract][Full Text] [Related]
7. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature.
Cossu G; Levivier M; Daniel RT; Messerer M
Biomed Res Int; 2015; 2015():267831. PubMed ID: 26146614
[TBL] [Abstract][Full Text] [Related]
8. Meningiomas, epidermal growth factor and progesterone.
Koper JW; Lamberts SW
Hum Reprod; 1994 Jun; 9 Suppl 1():190-4. PubMed ID: 7962464
[TBL] [Abstract][Full Text] [Related]
9. Meningioma and hormonal influences.
Wahab M; Al-Azzawi F
Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
[TBL] [Abstract][Full Text] [Related]
10. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C
J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781
[TBL] [Abstract][Full Text] [Related]
11. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Grunberg SM; Weiss MH; Russell CA; Spitz IM; Ahmadi J; Sadun A; Sitruk-Ware R
Cancer Invest; 2006 Dec; 24(8):727-33. PubMed ID: 17162554
[TBL] [Abstract][Full Text] [Related]
12. Management of patients receiving long-term treatment with mifepristone.
Spitz IM; Grunberg SM; Chabbert-Buffet N; Lindenberg T; Gelber H; Sitruk-Ware R
Fertil Steril; 2005 Dec; 84(6):1719-26. PubMed ID: 16359971
[TBL] [Abstract][Full Text] [Related]
13. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
14. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
Olson JJ; Beck DW; Schlechte JA; Loh PM
J Neurosurg; 1987 Apr; 66(4):584-7. PubMed ID: 3559725
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone: antineoplastic studies.
Sartor O; Figg WD
Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
[TBL] [Abstract][Full Text] [Related]
16. Role of antiprogestational therapy for meningiomas.
Grunberg SM
Hum Reprod; 1994 Jun; 9 Suppl 1():202-7. PubMed ID: 7962466
[TBL] [Abstract][Full Text] [Related]
17. Large endometrial polyp in a patient on long-term mifepristone therapy.
Martineau PA; Levental M
J Ultrasound Med; 2000 Jul; 19(7):487-9. PubMed ID: 10898303
[No Abstract] [Full Text] [Related]
18. Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells.
Koper JW; Foekens JA; Braakman R; Lamberts SW
Cancer Res; 1990 May; 50(9):2604-7. PubMed ID: 2183929
[TBL] [Abstract][Full Text] [Related]
19. RU486 (mifepristone): mechanisms of action and clinical uses.
Cadepond F; Ulmann A; Baulieu EE
Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of the antiprogestins.
Kettel LM
Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
